Medicine
Showing 1,001-1,100 of 2,413 Results
-
Andreas Kerschbaumer
Postdoctoral Scholar, Immunology and Rheumatology
BioDr. Andreas Kerschbaumer is a postdoctoral scholar in the Division of Immunology and Rheumatology at Stanford University, conducting research in the Robinson and Khatri Labs. His work integrates clinical rheumatology with computational and systems immunology, applying meta-analytic techniques on transcriptomic datasets to uncover mechanisms of autoimmunity and improve therapeutic strategies in rheumatology.
He trained in internal medicine and rheumatology at the Medical University of Vienna, Department of Medicine III, Division of Rheumatology, where he also completed his PhD under Professors Smolen and Aletaha on treatment outcomes in inflammatory arthritis, followed by his habilitation on strategies to optimize the interpretation of clinical trial data in rheumatoid and psoriatic arthritis.
Dr. Kerschbaumer has been actively engaged with the European Alliance of Associations for Rheumatology (EULAR), contributing as Fellow, Methodologist, and Co-Methodologist to multiple international taskforces, including the 2019, 2022, and 2025 rheumatoid arthritis recommendations and the 2019 and 2023 psoriatic arthritis recommendations. He is currently a member of the EULAR Quality of Care Committee and serves as Co-Abstract Chair of the ACR Rheumatoid Arthritis abstract committee. -
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
-
Ali Raza Khaki, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Khaki is a medical oncologist and clinical assistant professor at Stanford University School of Medicine.
In his clinical practice, he treats patients with all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. He also regularly attends on the inpatient oncology service at Stanford Hospital.
With each patient, he is devoted to providing exceptional, humanistic care and has been recognized throughout his career for his humanism. As a medical student, he was named to the national Gold Humanism Honor Society and he received the Reza Gandjei Humanism Award as a medical resident at UCSF.
His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He is the site principal investigator for multiple clinical trails investigating new therapies for genitourinary cancers.
Dr. Khaki is also active working clinically in inpatient oncology and is a Unit Based Medical Director for G1, an oncology hospital unit and is the Director of Inpatient Oncology. In this role, he oversees the inpatient oncology teams, works closely with the cancer center to develop new transitions of care pathways from inpatient to outpatient and has co-led an inpatient oncology research group to study quality improvement, care delivery and end-of-life care for patients with cancer.
Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.
He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. In addition, he is an editor for HemOnc.org and theMednet, a physician-only online community where members share clinical questions and answers. -
Saad A. Khan, MD
Associate Professor of Medicine (Oncology)
BioDr. Khan is a fellowship-trained cancer specialist with board certification in oncology and hematology. He is an assistant professor in the Department of Medicine, Division of Oncology.
Dr. Khan focuses on the treatment of head and neck cancers, advanced thyroid cancers, and neuroendocrine tumors. He recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.
Dr. Khan’s research interests include therapeutic clinical trials as well as ways to reduce toxicities that some patients may experience when receiving cancer treatment. His research activities include ongoing clinical trials of targeted and immune therapy for aggressive thyroid cancer.
He has published numerous articles on his research discoveries in peer-reviewed journals such as the JAMA Oncology, Investigational New Drugs, and others. Topics include new drug treatments for small cell lung cancer and for cancers of the head and neck, racial and gender disparities in certain types of cancer, and management of the potentially toxic effects of cancer therapies.
Dr. Khan is a member of the NRG Head and Neck Committee. NRG brings together internationally recognized groups (the first words in their names form the acronym “NRG”) to conduct cancer clinical research and share study results. The objective is to inform clinical decision making and healthcare policy worldwide.
Dr. Khan is a member of the ECOG Head and Neck Core and Thoracic Committees. ECOG (Eastern Cooperative Oncology Group) is part of one of the five groups of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) Program.
He also is a member of the National Cancer Institute’s Central IRB for Early Phase Clinical Trials.
When not providing patient care or conducting research, Dr. Khan enjoys spending time with his family, hiking, and relaxing at the beach. -
Abha Khandelwal
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular disease in Pregnancy
Valvular Heart Disease
Cardiomyopathy
Pericardial disease
Heart Disease in South Asians
Women's Cardiovascular Disease -
Sarita Khemani
Clinical Associate Professor, Medicine
BioDr. Sarita Khemani is a Clinical Associate Professor of Medicine at Stanford University School of Medicine, a Hospital Medicine physician, and the founding Director of STRIVE, the Stanford Resilience & Longevity Initiative.
Her academic work focuses on physiological reserve as a central concept in longevity medicine — the biological capacity that allows individuals to maintain strength, cognition, independence, and recovery potential across the lifespan. Through Stanford STRIVE, she is advancing a clinically grounded approach to measuring and strengthening resilience across aging, illness, hospitalization, surgery, and recovery.
Dr. Khemani’s clinical expertise is in perioperative medicine and the care of neurosurgical patients, with a focus on preventing and managing medical complications around surgery. This work has shaped a central question in her academic work: why do some individuals recover well after surgery, illness, or biological stress, while others experience accelerated functional decline?
A dedicated educator, Dr. Khemani has served as Director of the Perioperative Medicine Rotation for medical students, Stanford Medicine residents and physician assistant students. She is a recipient of the Department of Medicine’s Excellence in Teaching Award.
Dr. Khemani is the founder and co-director of the Stanford Medicine Clinical Summer Internship (SMCSI), a globally recognized program that exposes premedical students to the clinical and academic world of medicine. Under her leadership, the inclusive program has expanded access to medical training through numerous scholarships for students representing a range of experiences, with a mission to empower future leaders in healthcare.
Dr. Khemani is an invited speaker at national and international medical meetings, has presented at Stanford Neurosurgery Grand Rounds, and delivered the keynote address at the Stanford Physician Assistant Program’s graduation ceremony. She has also been featured on U.S. media platforms and international television as a guest expert.
Dr. Khemani is a member of the American College of Physicians and serves on the Stanford Hospital Pharmacy and Therapeutics Committee and the Hospital Medicine Wellness Committee. -
Amy Khokhar
Temporary Employee, Medicine - Med/Stanford Prevention Research Center
Current Role at StanfordStanford Lifestyle Medicine Program Administrator
-
Nitasha Khullar, MD
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr. Nitasha Khullar is a board-certified, fellowship-trained rheumatologist at Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Immunology and Rheumatology at Stanford University School of Medicine.
Dr. Khullar specializes in caring for people with autoimmune and inflammatory diseases that affect the joints, muscles, and immune system. She treats conditions like lupus, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, vasculitis, gout and other complex rheumatic disorders. She provides personalized care for each patient, focusing on early diagnosis and working closely with other medical specialists to help manage these diseases. She values shared decision-making and a patient-centric approach to her care.
Dr. Khullar’s work has been presented at national and international conferences, including the American College of Rheumatology and the American Association of Immunology. She has authored peer-reviewed publications in journals such as Viruses, Molecular Neurobiology, Age (Dordrecht, Netherlands), and Current Treatment Options in Rheumatology.
She is a member of the American College of Rheumatology. -
Kiran Khush, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Khush's clinical research interests include the evaluation of donors and recipients for heart transplantation; mechanisms of adverse outcomes after heart transplantation, including cardiac allograft vasculopathy and antibody-mediated rejection; and development of non-invasive diagnostic approaches for post-transplant monitoring.
-
Michaela Kiernan
Senior Research Scholar, Medicine - Med/Stanford Prevention Research Center
Current Research and Scholarly InterestsResearch interests include the design and experimental testing of innovative strategies to improve recruitment and retention of randomized clinical trials.
-
Joel Killen
Professor (Research) of Medicine (General Internal Medicine), Emeritus
Current Research and Scholarly InterestsMy research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults.
-
Donghee Kim, MD, PhD
Social Science Research Scholar, Medicine - Med/Gastroenterology and Hepatology
BioI am a physician with specialized training in gastroenterology and hepatology. My research primarily focuses on clinical research of metabolic dysfunction-associated steatotic liver disease (MASLD), chronic liver diseases, and obesity-related gastrointestinal diseases, focusing on a population-based study. In addition, my research has expanded to encompass areas such as cardiology, endocrinology, neurology, and psychiatry. I have extensive experience in large epidemiologic cohort studies as well as clinical trials. This work has resulted in over 250 published papers in prominent journals, including Gastroenterology, Journal of Hepatology, Gut, Hepatology, and Clinical Gastroenterology and Hepatology, serving as the first and corresponding author. These publications have been cited more than 18,000 times.
-
Gloria S. Kim
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsAsian Health
Medical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction -
Jackson Kim, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Kim is a Clinical Assistant Professor in the Division of Nephrology at Stanford Health Care.
Dr. Kim diagnoses and treats a range of conditions affecting the kidneys, including glomerulonephritis, nephrotic syndrome, chronic kidney disease, and genetic kidney disease. He creates a customized, comprehensive treatment plan for every patient he serves.
Dr. Kim has a keen research interest in glomerular kidney disease, particularly glomerulonephritis. He has authored manuscripts, conducted case studies, and published his work in several peer-reviewed journals. -
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
(http://kimlab.stanford.edu) -
Kaitlyn Kim
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2025
Stanford Student Employee, Health PolicyCurrent Research and Scholarly InterestsCancer Immunotherapy, Solid Tumors, Early-Stage Neurodegeneration, Healthy Aging, Sleep Dysregulation.
-
Kyung Mi Kim
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioKyung Mi Kim, PhD, RN, is a Clinical Assistant Professor at Stanford University, School of Medicine. She has expertise in quantitative methods, including econometrics, large data analysis, and the evaluation of value-based payment policies. She is passionate about care models that lower the cost of high-quality care for frail, older surgical patients and their caregivers, partnering with leaders in health care, science, and technology to achieve the greatest impact.
-
Nathan Geonwoo Kim, MD, MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Nathan Geonwoo Kim is a board-certified, fellowship-trained transplant hepatologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.
Dr. Kim specializes in hepatology and liver transplantation (transplant hepatology). He cares for people with severe liver disease, such as cirrhosis, alcohol-associated hepatitis, and metabolic dysfunction-associated steatotic liver disease. Dr. Kim also provides personalized liver cancer care, which may include targeted therapies or liver transplantation to achieve the best possible outcomes.
With a Master of Science in epidemiology and clinical research, Dr. Kim studies hepatocellular carcinoma and outcomes in chronic liver disease. His research focuses on ways to deliver better, more equitable care to people with liver diseases.
Dr. Kim has published his findings in leading medical journals, including the Journal of Hepatology, Clinical Gastroenterology and Hepatology, and Cancer. He has also shared his expertise at national and international conferences, including Digestive Disease Week, The Liver Meeting, and the International Liver Congress. -
Paige Livingston, PA-C
Physician Assistant - Research, Medicine - Med/Blood and Marrow Transplantation
BioPaige has an undergraduate degree in Nutrition from Cal Poly, SLO and completed her Master’s degree in Physician Assistant Studies at Western University of Health Sciences in Southern California before moving to the bay area in November 2016 to join the Stanford Bone Marrow Transplant & Cancer Cell Therapy team. She believes in providing quality care with compassion, taking time to listen to patients and families and helping them navigate complex medical situations and decisions. She has lead the project for APP involvement in Bone Marrow Harvests and serves on the planning committee for a local APP Oncology conference. Her area of clinical practice is bone marrow transplantation and cancer cell therapy.
-
Seung K. Kim M.D., Ph.D.
KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)
Current Research and Scholarly InterestsPancreatic islets are essential for human health. We study the development and function of islet cells using modern methods in several model systems, including mice, pigs, human pancreas, primates, embryonic stem cells, and fruit flies. We have discovered critical factors required for islet development and mature islet cell function. These approaches have informed efforts to generate replacement islets, and provide immune protection of transplanted islets for diabetes.
-
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsWe are interested in studying the pathophysiological processes that contribute to glucose intolerance and type 2 diabetes mellitus. My current research focuses on characterizing pancreatic beta-cell function in populations with significant insulin resistance and vulnerability to developing diabetes: individuals with schizophrenia, morbid obesity, and history of gestational diabetes.
-
Yeuen Kim
Clinical Associate Professor, Medicine - Vaden Health Center
BioYeuen Kim MD MAS is an internal medicine physician with expertise in population health, medical humanities educational interventions, and working with vulnerable populations in urban settings. She trained at Brown University's Program in Liberal Medical Education and completed residency/chief residency at the Santa Clara Valley Medical Center in San Jose, CA. She has worked with vulnerable populations in ambulatory and mobile settings as a primary care attending and medical outreach physician, as well as completing a Masters' and fellowship in clinical research at UCSF's Department of Biostatistics and Epidemiology & SFGH DGIM, where she evaluated electronic referrals to subspecialty clinics from safety settings (Kim, Chen et al, JGIM 2009.) She worked with the SF and Santa Clara County public health departments to help reduce mortality and improve COVID19 and mpox mitigation, especially at congregate residential facilities through better ventilation, public-private collaboration, and addressing determinants of health for essential workers. Since 2013, she has facilitated art gallery-based workshops for physicians and learners to improve observation and communication skills. She co-leads narrative medicine and oncology workshops for students, residents (Edwards, Kim et al, BMJ Educ 2022) and faculty as a clinical associate professor in Primary care and population health.
-
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Current Research and Scholarly InterestsClinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
-
Christian Kindermann
Research Engineer, Computational Medicine
Current Role at StanfordI am a research engineer specializing in semantic technologies (ontologies and knowledge graphs). My work focuses on helping life-science practitioners and researchers manage their data.
-
Abby C. King
David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
On Partial Leave from 05/01/2026 To 04/30/2027Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
-
Nadia Kirmani
MD Student with Scholarly Concentration in Clinical Research / Immunology, expected graduation Spring 2027
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2025BioBS in Biology & BA in English, Duke University (2019)
Honors: Summa Cum Laude, Phi Beta Kappa
Nadia's research interests include targeted cancer therapeutic development and health equity. -
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (Computational Medicine) and, by courtesy, of Genetics
On Partial Leave from 01/16/2026 To 12/18/2026Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer -
Samantha M.R. Kling
Quantitative Research Scientist, Medicine - Primary Care and Population Health
Current Role at StanfordQuantitative Research Scientist in the Evaluation Sciences Unit (ESU)
-
Joshua W. Knowles
Associate Professor of Medicine (Cardiovascular Medicine)
On Partial Leave from 06/01/2026 To 08/31/2026Current Research and Scholarly InterestsGenetic basis of coronary disease
Genetic basis of insulin resistance
Familial Hypercholesterolemia (FH) -
Matthew Kohrman
Associate Professor of Anthropology, and by courtesy, of Medicine (Stanford Prevention and Research Center) and Senior Fellow, by courtesy, at the Freeman Spogli Institute for International Studies
BioMatthew Kohrman’s research and writing bring anthropological methods to bear on the ways health, culture, and politics are interrelated. Focusing on the People's Republic of China, he engages various intellectual terrains such as governmentality, gender theory, political economy, critical science studies, narrativity, and embodiment. His first monograph, Bodies of Difference: Experiences of Disability and Institutional Advocacy in the Making of Modern China, raises questions about how embodied aspects of human existence, such as our gender, such as our ability to propel ourselves through space as walkers, cyclists and workers, become founts for the building of new state apparatuses of social provision, in particular, disability-advocacy organizations. Over the last decade, Prof. Kohrman has been involved in research aimed at analyzing and intervening in the biopolitics of cigarette smoking among Chinese citizens. This work, as seen in his recently edited volume--Poisonous Pandas: Chinese Cigarette Manufacturing in Critical Historical Perspectives--expands upon heuristic themes of his earlier disability research and engages in novel ways techniques of public health, political philosophy, and spatial history. More recently, he has begun projects linking ongoing interests at the intersection of phenomenology and political economy with questions regarding environmental attunement and the arts.
-
Qinqin Kong
Postdoctoral Scholar, General Internal Medicine
BioI am currently a Postdoctoral Scholar in the Departments of Medicine and Health Policy at Stanford University, after earning a PhD in atmospheric science from Purdue University. My research interests lie at the intersection of climate change—particularly extreme heat—and human society. I aim to advance our understanding of the physical mechanisms, cascading impacts, and the effectiveness of potential mitigation strategies for human heat stress. My PhD research focused on how land-atmosphere interactions modulate heat stress, as well as the economic and energy impacts of increasing heat stress in the context of climate change. My postdoctoral research at Stanford evaluates the impact of heat stress on public health, especially human fertility, in low- and middle-income countries. My methodological areas of expertise include climate modeling, human biophysics modeling, and econometric modeling, which I am further developing at Stanford.
-
Michael Kozal
Professor of Medicine (Infectious Diseases)
BioDr. Kozal is a Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine and is the Director of Operations for the Department of Medicine Clinical Research Hub. He previously served as Senior Associate Dean for Veteran Affairs at Stanford School of Medicine and Chief of Staff at VA Palo Alto Health Care System. Prior to coming to Stanford, he was a Professor of Medicine at Yale University School of Medicine and served as Associate Dean for Veteran Affairs at Yale University School of Medicine and the Chief of Staff at VA Connecticut Healthcare System.
Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and was a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents from 2015-2024.
Dr. Kozal is currently serving as the overall Director of Operations for the Department of Medicine Clinical Research Hub. The key hub functions include research navigation, enhanced pre-award support for budgeting and submission strategy, streamlined contracting with research sponsors, a multisite clinical coordination center to coordinate and monitor complex studies, and a centralized digital platform for study design, data access, and analytics.
Dr. Kozal sees patients in the Infectious Diseases Clinic and the Valley Fever Clinic in Palo Alto. -
Fredric Kraemer
Gerald M. Reaven, MD, Professor of Endocrinology, Emeritus
Current Research and Scholarly InterestsOur research interests are in the general area of cellular lipid and lipoprotein metabolism. The work is aimed primarily at understanding the mechanisms regulating cholesterol and triglyceride accumulation in cells. We utilize a variety of techniques from cell biology, biochemistry, and molecular biology.
-
Daniel Kraft, MD
Adjunct Professor, Med/Hospital Medicine
BioDaniel Kraft is a Stanford and Harvard-trained physician-scientist, inventor, and entrepreneur with more than 25 years of experience across clinical practice, biomedical research, and healthcare innovation.
He earned his bachelor's degree in biochemistry from Brown University and his medical degree from Stanford University School of Medicine, completed the Harvard Combined Residency in Internal Medicine and Pediatrics, and went on to fellowships in hematology, oncology, and bone marrow transplantation at Stanford and a postdoctoral research fellowship in the laboratory of Irving L. Weissman.
His academic research has spanned stem cell biology and regenerative medicine, stem cell–derived immunotherapies for cancer, and the bioengineering of human T-cell differentiation, with work published in journals including Nature and Science. He holds medical device, immunology, and stem cell–related patents, and is the inventor of the MarrowMiner, an FDA-cleared device for minimally invasive bone marrow harvesting.
Dr. Kraft is the Founder and Chair of NextMed Health (formerly Exponential Medicine), Founder of Digital.Health, and Managing Partner of Continuum Health Ventures, an early-stage fund focused on democratizing health and improving healthspan. A frequent voice on the future of medicine, he has delivered four TED and two TEDMED talks and keynotes worldwide. He is also a member of the inaugural class of the Aspen Institute Health Innovators Fellowship and the Kauffman Fellows Society. -
Beatrix Krause-Sorio
Senior Program Manager, Medicine - Med/Cardiovascular Medicine
Current Role at StanfordSenior Program Manager
-
Kristina Kudelko
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsDrugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, evaluating the long-term impacts of a standardized pulmonary vascular disease fellowship training program
-
Andre Kumar MD, MEd
Clinical Associate Professor, Medicine
BioDr. Andre Kumar is a Clinical Professor in the Stanford Division of Hospital Medicine with a passion for improving patient care through Point-of-Care Ultrasound (POCUS), clinical research, and education. He earned his MD from Tulane University and completed his residency, chief residency, and a Master's in Education at Stanford University.
Dr. Kumar has extensive experience in creating, operationalizing, and leading multi-center clinical trials, including investigations related to POCUS, COVID-19 therapeutics, procedural safety, and the long-term health consequences of infections on the heart and lungs. He continues to conduct research and teach POCUS on a local and national level, and is committed to improving the science and education that underlie the next generation of diagnostic tools. Currently, his research focuses on the impact of artificial intelligence (AI) on numerous healthcare applications, particularly for the improving the accuracy of clinician diagnosis, evidence-based management, and medical imaging.
Dr. Kumar is also a committed educator and mentor to the next generation of physicians. His contributions to medical education have been recognized with several awards, including the Lawrence H. Mathers Award for Exceptional Commitment to Teaching (2023), the Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching (2018, 2022), and the David A. Rytand Clinical Teaching Award (2018, 2022, and 2025). Dr. Kumar has contributed to the creation of free educational content for POCUS, including videos for the Stanford Medicine 25 series, New England Journal of Medicine, and JAMA, which have amassed over 1,000,000 views worldwide.
Dr. Kumar has held numerous leadership positions that reflect his commitment to advancing medical education and clinical practice. He is also the Co-Founder and Director of the SHAPE Program in the Stanford Internal Medicine Residency Program and Co-Director of Clinical Reasoning at Stanford School of Medicine. He previously served as President for the Society of Hospital Medicine Bay Area and Director of the Rathmann Medical Education Fellowship.
List of publications: https://bit.ly/3eop95i
ClinicalTrials.Gov registration:
https://bit.ly/2TizOmD
https://bit.ly/2zeNBjJ
Media:
https://shorturl.at/rNU46
https://stanfordmedicine.box.com/s/jm3544zdwpihj6bstcv72x76zq9nuzbq
https://bit.ly/33MZa0O
https://bit.ly/3t8HE2u
https://wb.md/2zfjY1N -
Parth I Kumar
Postdoctoral Medical Fellow, Nephrology
Fellow in Medicine - Med/NephrologyBioParth Kumar is a fellow in the Stanford University Nephrology Fellowship Program. Dr. Kumar holds a B.A. in Molecular and Cell Biology from UC Berkeley and an M.D. with Distinction from UCSF School of Medicine. He completed his Internal Medicine Residency at UC Irvine, where he was recognized as the Intern Teacher of the Year in 2022. Dr. Kumar's research interests span health care innovation and translational medicine, such as integrating 3D printing into clinical settings to aid patient education, evaluating novel medical devices. His past work includes the study "Evaluating the use of Radioactive Analogs of Doxorubicin for Quantifying ChemoFilter binding and Whole Body PET/MRI Biodistribution," leading to him being recognized as one of the JVIR Editor's Honorees: Distinguished Laboratory Investigations in 2022.
-
Calvin Kuo
Maureen Lyles D'Ambrogio Professor
Current Research and Scholarly InterestsWe study cancer biology, intestinal stem cells (ISC), and angiogenesis. We use primary organoid cultures of diverse tissues and tumor biopsies for immunotherapy modeling, oncogene functional screening and stem cell biology. Angiogenesis projects include blood-brain barrier regulation, stroke therapeutics and anti-angiogenic cancer therapy. ISC projects apply organoid culture and ko mice to injury-inducible vs homeostatic stem cells and symmetric division mechanisms.
-
Clair Mariam Kuriakose
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioClair Kuriakose is a Physician Assistant with a clinical background in Pediatric Surgery. She joined Stanford September 2014 as the first Manager of Advanced Practice with the Center for Advanced Practice and officially transitioned to the Executive Director of Advanced Practice on August 2017. Clair is passionate about the value advanced practice providers bring to the complex and ever-changing healthcare industry and truly enjoys collaborating with the various Advanced Practice Providers in the organization to ensure the best care for our patients.
-
Allison W. Kurian, M.D., M.Sc.
Colleen Haas Chair in the School of Medicine, Professor of Medicine (Oncology) and of Epidemiology and Population Health
Current Research and Scholarly InterestsI aim to understand cancer burden and improve treatment quality at the population level. I have a strong focus on genetic risk assessment and precision oncology. I lead epidemiologic studies of cancer risk factors, clinical trials of novel approaches to cancer risk reduction, and decision analyses of strategies to optimize cancer outcomes.
-
Lianne Kurina
David and Lucile Packard Foundation Professor of Human Biology and Professor (Teaching), by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy recent research has focused on the physical and mental health of military service members. I'm now working with colleagues at the VA.
-
David Kurtz
Adjunct Clinical Assistant Professor, Medicine - Oncology
Current Research and Scholarly InterestsImplementation of noninvasive detection of malignancies in the clinic remains difficult due to both technical and clinical challenges. These include necessary improvements in sensitivity and specificity of biomarkers, as well as demonstration of clinical utility of these assays. My research focuses on technical development and implementation of assays to detect and track cancers in order to facilitate personalized disease management.
-
Ware Kuschner, M.D.
Professor of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsOccupational and environmental lung disease; Pulmonary and systemic responses to toxicant inhalation; Indoor and outdoor air pollution health effects;
-
Wilson F Kuswanto, MD, PhD
Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr. Kuswanto is a physician scientist, board-certified Rheumatologist and instructor in medicine at Stanford University School of Medicine. He is currently working with Garry Nolan, PhD and William Robinson MD, PhD to unravel the tissue immune responses in Rheumatologic diseases. Dr. Kuswanto obtained his medical degree at Harvard Medical School, earning his PhD in Immunology with Diane Mathis and Christophe Benoist where he uncovered the role of the immune system in tissue repair and regeneration. He later moved to Stanford University to complete his residency training and Rheumatology fellowship.
-
Paul Kwo
Professor of Medicine (Gastroenterology and Hepatology)
BioDr. Kwo is currently Professor of Medicine and Director of Hepatology at the Stanford University where he joined the faculty in November 2016. Prior to joining the faculty at Stanford, he was at Indiana University for 21 years where he served as the Medical Director of Liver Transplantation. He has distinguished himself in the field of Hepatitis C therapeutics and has been the principal investigator on multiple international trials. He recently authored the ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
-
Allison Kwong
Assistant Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Surgery (Abdominal Transplantation)
Current Research and Scholarly InterestsCirrhosis, portal hypertension, liver transplantation, transplant outcomes, organ allocation, population health, quality and systems improvement
-
Uri Ladabaum
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsGastrointestinal cancer prevention and risk management. Risk stratification. Cost-effectiveness analysis. Health services research.
